Meeting the Challenge: Transforming Patient Care in sHTG and FCS With Novel RNA-Based Therapies
Webinar/Online
Saturday, March 29, 2025 at 7:00pm CT - 8:30pm CT
This event has ended.
Info
Topic
Join leading experts at this ACC satellite symposium to explore the latest advancements in RNA-based therapies for severe hypertriglyceridemia (sHTG) and familial chylomicronemia syndrome (FCS). Gain insights into emerging clinical data, patient selection, and the evolving treatment landscape to optimize care for these high-risk patients.
Additional Information
Goal Statement
The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Dyslipidemia.
Target Audience
This educational program is intended for cardiology physicians, nurse practitioners, and physician associates who care for patients with sHTG, including FCS.
Speakers
United States of America
JS Abercrombie Chair, Atherosclerosis and Lipoprotein Research
Professor of Medicine and Molecular and Human Genetics
Baylor College of Medicine
Chief, Cardiology and Cardiovascular Research
Director, Center for Cardiometabolic Di
Fred M. Parrish Professor of Cardiology and Molecular Medicine
Director, Center for Prevention of Cardiovascular Disease
Section on Cardiovascular Medicine
Wake Forest University School of Medicine
Winston Salem, NC